Literature DB >> 4164249

Protection against lethality of E. coli endotoxin with "O" antiserum.

W J Tate, H Douglas, A I Braude, W W Wells.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 4164249     DOI： 10.1111/j.1749-6632.1966.tb52403.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  26 in total

Review 1.  Bloodstream infections: epidemiology, pathophysiology and therapeutic perspectives.

Authors:  R Salomão; O Rigato; A C Pignatari; M A Freudenberg; C Galanos
Journal:  Infection       Date:  1999 Jan-Feb       Impact factor: 3.553

2.  Humoral immunity to gram-negative bacillary infections in experimental animals and man.

Authors:  W R McCabe
Journal:  Infection       Date:  1975       Impact factor: 3.553

3.  Delaying approval of a critical drug: safety, efficacy, economics, compassion.

Authors:  Leo T Rosenberg
Journal:  J Med Humanit       Date:  1994

4.  Passive immunization to outer membrane proteins MLP and PAL does not protect mice from sepsis.

Authors:  Catherine H Valentine; Judith Hellman; Laura K Beasley-Topliffe; Aranya Bagchi; H Shaw Warren
Journal:  Mol Med       Date:  2006 Sep-Oct       Impact factor: 6.354

5.  Early 2-mercaptoethanol-resistant antibody production in endotoxin-treated rats.

Authors:  K Merétey; E Elekes; L Bertók
Journal:  Infect Immun       Date:  1970-01       Impact factor: 3.441

Review 6.  Immunoprophylaxis and immunotherapy of gram-negative sepsis and shock with antibodies to core glycolipids and lipid A of bacterial lipopolysaccharides.

Authors:  I G Mitov; D G Terziiski
Journal:  Infection       Date:  1991 Nov-Dec       Impact factor: 3.553

7.  Antibody WN1 222-5 mimics Toll-like receptor 4 binding in the recognition of LPS.

Authors:  Kathryn Gomery; Sven Müller-Loennies; Cory L Brooks; Lore Brade; Paul Kosma; Franco Di Padova; Helmut Brade; Stephen V Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-26       Impact factor: 11.205

8.  Immunogenic and toxic properties of a purified lipopolysaccharide-protein complex from Pasteurella multocida.

Authors:  D J Ganfield; P A Rebers; K L Heddleston
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

9.  Human antiserum for prevention of the local shwartzman reaction and death from bacterial lipopolysaccharides.

Authors:  E J Ziegler; H Douglas; A I Braude
Journal:  J Clin Invest       Date:  1973-12       Impact factor: 14.808

10.  Blood group isoantibody stimulation in man by feeding blood group-active bacteria.

Authors:  G F Springer; R E Horton
Journal:  J Clin Invest       Date:  1969-07       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.